Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00963989 · ClinicalTrials.gov registry record · NA

Imaging Guided Patient Selection for Interventional Revascularization Therapy

A NA study of Acute Ischemic Stroke, sponsored by Penumbra.

Completed
Registry status
NA
Development phase
146
Enrollment target
1
Study location

NCT00963989: Completed NA study of Acute Ischemic Stroke, sponsored by Penumbra.

NCT00963989 is a NA study of Acute Ischemic Stroke that has completed, run by Penumbra. The registered enrollment target is 146 participants, below the 346-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00963989, a NA study of Acute Ischemic Stroke, has completed, sponsored by Penumbra.

COMPLETED
Registry status
NA
Development phase
146 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this clinical evaluation is to determine the safety and effectiveness of the Penumbra System in a stroke cohort who presents within 8 hours from symptom and with a known core infarct volume at admission. The secondary objective is to determine if there is a correlation between infarct volume and functional outcome in treated patients at 90 days post-procedure.

Primary Outcome

Modified Rankin Scale (mRS) ranges from 0 to 5, with higher scores being worse.

Conditions Studied

Interventions

  • DEVICE Penumbra System

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2009-09
Est. Completion 2016-09
Phase NA
Penumbra

25 total trials

What the finished NCT00963989 record still lists

NCT00963989 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 346-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (58% lower).

The record links to 1 condition, with Acute Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Penumbra System is the first listed.

NCT00963989 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT00963989 about?

NCT00963989 is a clinical study titled "Imaging Guided Patient Selection for Interventional Revascularization Therapy". The primary objective of this clinical evaluation is to determine the safety and effectiveness of the Penumbra System in a stroke cohort who presents within 8 hours from symptom and with a known core infarct volume at admission. The secondary objective is to determine if there is a correlation betwe...

What is the current status of trial NCT00963989?

This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2009-09. Estimated completion is 2016-09.

What conditions does trial NCT00963989 study?

This clinical trial studies the following conditions: Acute Ischemic Stroke.

What interventions are being tested in trial NCT00963989?

The interventions under investigation include: Penumbra System (DEVICE).

Who is sponsoring clinical trial NCT00963989?

This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00963989 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Ischemic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00963989's enrollment target sits among peer trials

146 16th of 25 higher than 10 of 25 other Acute Ischemic Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Acute Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03490929 · 146 participants · Phase 4

    CEUS for Blunt Abdominal Trauma in Children

  • NCT04755062 · 146 participants · NA

    A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans

  • NCT04867954 · 146 participants

    Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis

  • NCT05051618 · 146 participants · NA

    Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00963989, the US trial registry maintained by the National Library of Medicine. NCT00963989 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.